Relationship between plasma lipids and all-cause mortality in nondemented elderly.

PubWeight™: 1.44‹?› | Rank: Top 5%

🔗 View Article (PMID 15673344)

Published in J Am Geriatr Soc on February 01, 2005

Authors

Nicole Schupf1, Rosann Costa, Jose Luchsinger, Ming-Xin Tang, Joseph H Lee, Richard Mayeux

Author Affiliations

1: G. H. Sergievsky Center, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA.

Articles citing this

Hispanic mortality paradox: a systematic review and meta-analysis of the longitudinal literature. Am J Public Health (2013) 1.37

Association of lipoprotein levels with mortality in subjects aged 50 + without previous diabetes or cardiovascular disease: a population-based register study. Scand J Prim Health Care (2013) 1.29

Metabolic syndrome and dementia risk in a multiethnic elderly cohort. Dement Geriatr Cogn Disord (2007) 1.16

Relation of plasma lipids to all-cause mortality in Caucasian, African-American and Hispanic elders. Age Ageing (2008) 1.07

Lipid-lowering treatment to the end? A review of observational studies and RCTs on cholesterol and mortality in 80+-year olds. Age Ageing (2010) 1.06

Association of body mass index with all-cause and cardiovascular disease mortality in the elderly. PLoS One (2014) 1.05

The association of hypertriglyceridemia with cardiovascular events and pancreatitis: a systematic review and meta-analysis. BMC Endocr Disord (2012) 0.98

Serum total cholesterol levels and all-cause mortality in a home-dwelling elderly population: a six-year follow-up. Scand J Prim Health Care (2010) 0.96

Apolipoprotein E gene is related to mortality only in normal weight individuals: the Rotterdam Study. Eur J Epidemiol (2007) 0.96

The lipid profile and mortality risk in elderly type 2 diabetic patients: a ten-year follow-up study (ZODIAC-13). PLoS One (2009) 0.92

Lipids and all-cause mortality among older adults: a 12-year follow-up study. ScientificWorldJournal (2012) 0.87

A prospective study of risk factors for cardiovascular events among the elderly. Clin Interv Aging (2012) 0.84

Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review. BMJ Open (2016) 0.84

Cardiovascular disease risk scores in identifying future frailty: the Whitehall II prospective cohort study. Heart (2013) 0.83

Prevalence of frailty indicators and association with socioeconomic status in middle-aged and older adults in a swiss region with universal health insurance coverage: a population-based cross-sectional study. J Aging Res (2014) 0.83

Serum total cholesterol concentration and 10-year mortality in an 85-year-old population. Clin Interv Aging (2014) 0.82

Effect of obesity, serum lipoproteins, and apolipoprotein E genotypes on mortality in hospitalized elderly patients. Rejuvenation Res (2011) 0.81

Health beliefs and desire to improve cholesterol levels among patients with hyperlipidemia. Patient Educ Couns (2015) 0.81

Low-density lipoprotein cholesterol was inversely associated with 3-year all-cause mortality among Chinese oldest old: data from the Chinese Longitudinal Healthy Longevity Survey. Atherosclerosis (2015) 0.79

All-cause mortality in patients with type 2 diabetes in association with achieved hemoglobin A(1c), systolic blood pressure, and low-density lipoprotein cholesterol levels. PLoS One (2014) 0.77

Cholesterol and cardiovascular disease in the elderly. Facts and gaps. Aging Dis (2013) 0.76

Serum Cholesterol Levels within the High Normal Range Are Associated with Better Cognitive Performance among Chinese Elderly. J Nutr Health Aging (2016) 0.75

Basal body temperature as a biomarker of healthy aging. Age (Dordr) (2016) 0.75

Association of Aging-Related Endophenotypes With Mortality in 2 Cohort Studies: the Long Life Family Study and the Health, Aging and Body Composition Study. Am J Epidemiol (2015) 0.75

Comparison of serum lipid management between elderly and non-elderly patients with and without coronary heart disease (CHD). Prev Med Rep (2016) 0.75

Sex Differences in Biological Markers of Health in the Study of Stress, Aging and Health in Russia. PLoS One (2015) 0.75

Nonlinear associations between plasma cholesterol levels and neuropsychological function. Neuropsychology (2016) 0.75

Combining LDL-C and HDL-C to predict survival in late life: The InChianti study. PLoS One (2017) 0.75

Articles by these authors

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.26

Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med (2012) 14.14

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07

The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet (2007) 9.80

Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma. Mol Cancer Ther (2007) 7.08

An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms. Cancer Res (2007) 5.63

Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet (2010) 5.52

Apolipoprotein E, Alzheimer disease, and African Americans. Arch Neurol (2003) 4.63

Mediterranean diet and risk for Alzheimer's disease. Ann Neurol (2006) 4.38

Epidemiology of Alzheimer disease. Nat Rev Neurol (2011) 4.13

Hypertension and the risk of mild cognitive impairment. Arch Neurol (2007) 3.62

A summary risk score for the prediction of Alzheimer disease in elderly persons. Arch Neurol (2010) 3.52

Stroke and the risk of Alzheimer disease. Arch Neurol (2003) 3.49

Mediterranean diet and mild cognitive impairment. Arch Neurol (2009) 3.40

Frequency and course of mild cognitive impairment in a multiethnic community. Ann Neurol (2008) 3.39

Retracted Integrative genomics identifies APOE ε4 effectors in Alzheimer's disease. Nature (2013) 3.35

Imaging hippocampal function across the human life span: is memory decline normal or not? Ann Neurol (2002) 3.34

Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families. PLoS One (2012) 3.11

Mediterranean diet, Alzheimer disease, and vascular mediation. Arch Neurol (2006) 2.98

Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch Neurol (2010) 2.91

Alcohol intake and risk of dementia. J Am Geriatr Soc (2004) 2.90

Pilot association study of the beta-glucocerebrosidase N370S allele and Parkinson's disease in subjects of Jewish ethnicity. Mov Disord (2005) 2.88

Hyperinsulinemia and risk of Alzheimer disease. Neurology (2004) 2.87

Relation of diabetes to mild cognitive impairment. Arch Neurol (2007) 2.86

Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center. Neurology (2005) 2.76

Brain morphology in older African Americans, Caribbean Hispanics, and whites from northern Manhattan. Arch Neurol (2008) 2.69

Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans. JAMA (2013) 2.58

Mediterranean diet and Alzheimer disease mortality. Neurology (2007) 2.45

Implementing diagnostic criteria and estimating frequency of mild cognitive impairment in an urban community. Arch Neurol (2005) 2.39

Caloric intake and the risk of Alzheimer disease. Arch Neurol (2002) 2.28

Literacy and memory decline among ethnically diverse elders. J Clin Exp Neuropsychol (2003) 2.27

Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants. PLoS Genet (2012) 2.23

The association between genetic variants in SORL1 and Alzheimer disease in an urban, multiethnic, community-based cohort. Arch Neurol (2007) 2.21

Shorter telomeres are associated with mortality in those with APOE epsilon4 and dementia. Ann Neurol (2006) 2.21

Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2. Ann Neurol (2012) 2.20

Antioxidant vitamin intake and risk of Alzheimer disease. Arch Neurol (2003) 2.20

GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease. Neuron (2013) 2.13

HGF/c-Met acts as an alternative angiogenic pathway in sunitinib-resistant tumors. Cancer Res (2010) 2.11

Relation of plasma lipids to Alzheimer disease and vascular dementia. Arch Neurol (2004) 2.09

Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08

Association of glucocerebrosidase mutations with dementia with lewy bodies. Arch Neurol (2009) 2.06

Validity of self-reported stroke in elderly African Americans, Caribbean Hispanics, and Whites. Arch Neurol (2009) 2.05

Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE. PLoS Genet (2011) 2.02

SORCS1 alters amyloid precursor protein processing and variants may increase Alzheimer's disease risk. Ann Neurol (2011) 2.01

Cardiovascular risk factors and Alzheimer's disease. Curr Atheroscler Rep (2004) 2.00

Comprehensive search for Alzheimer disease susceptibility loci in the APOE region. Arch Neurol (2012) 1.97

Albuminuria and dementia in the elderly: a community study. Am J Kidney Dis (2008) 1.96

The brain in the age of old: the hippocampal formation is targeted differentially by diseases of late life. Ann Neurol (2008) 1.92

Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease. Arch Neurol (2010) 1.91

Dietary factors and Alzheimer's disease. Lancet Neurol (2004) 1.90

Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network. Clin Investig (Lond) (2012) 1.90

Measures of adiposity and dementia risk in elderly persons. Arch Neurol (2007) 1.88

Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease. Proc Natl Acad Sci U S A (2008) 1.84

Long-term blood pressure fluctuation and cerebrovascular disease in an elderly cohort. Arch Neurol (2010) 1.80

Disparities in the recording of Parkinson's disease on death certificates. Mov Disord (2005) 1.75

Health and function of participants in the Long Life Family Study: A comparison with other cohorts. Aging (Albany NY) (2011) 1.74

Stroke and memory performance in elderly persons without dementia. Arch Neurol (2006) 1.65

Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis. Nat Genet (2012) 1.63

Identification of novel loci for Alzheimer disease and replication of CLU, PICALM, and BIN1 in Caribbean Hispanic individuals. Arch Neurol (2010) 1.61

Meta-analysis of the association between variants in SORL1 and Alzheimer disease. Arch Neurol (2011) 1.59

Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease. Proc Natl Acad Sci U S A (2013) 1.58

Association between SORL1 and Alzheimer's disease in a genome-wide study. Neuroreport (2007) 1.57

Association of shorter leukocyte telomere repeat length with dementia and mortality. Arch Neurol (2012) 1.55

Memory and executive function impairment predict dementia in Parkinson's disease. Mov Disord (2002) 1.52

Late-life depression, mild cognitive impairment, and dementia. JAMA Neurol (2013) 1.52

Imaging the Abeta-related neurotoxicity of Alzheimer disease. Arch Neurol (2007) 1.49

Functional correlates and prevalence of mild parkinsonian signs in a community population of older people. Arch Neurol (2005) 1.48

Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. Hum Mol Genet (2012) 1.46

Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease. Sci Transl Med (2014) 1.45

Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study: implication of additional loci. Arch Neurol (2008) 1.44

Regional white matter hyperintensity volume, not hippocampal atrophy, predicts incident Alzheimer disease in the community. Arch Neurol (2012) 1.44

Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. Genet Med (2011) 1.44

The genetics of adult-onset neuropsychiatric disease: complexities and conundra? Science (2003) 1.40

Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment. Arch Neurol (2005) 1.39

Do neuropsychological tests have the same meaning in Spanish speakers as they do in English speakers? Neuropsychology (2010) 1.37

Obesity and change in estimated GFR among older adults. Am J Kidney Dis (2009) 1.37